BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1514177)

  • 1. Coagulation factor IXa binding to activated platelets and platelet-derived microparticles: a flow cytometric study.
    Hoffman M; Monroe DM; Roberts HR
    Thromb Haemost; 1992 Jul; 68(1):74-8. PubMed ID: 1514177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor X bound to the surface of activated human platelets is preferentially activated by platelet-bound factor IXa.
    Scandura JM; Walsh PN
    Biochemistry; 1996 Jul; 35(27):8903-13. PubMed ID: 8688426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The second epidermal growth factor-like domain of human factor IXa mediates factor IXa binding to platelets and assembly of the factor X activating complex.
    Wong MY; Gurr JA; Walsh PN
    Biochemistry; 1999 Jul; 38(28):8948-60. PubMed ID: 10413468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annexin V inhibition of factor IXa-catalyzed factor X activation on human platelets and on negatively-charged phospholipid vesicles.
    London F; Ahmad SS; Walsh PN
    Biochemistry; 1996 Dec; 35(51):16886-97. PubMed ID: 8988028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
    Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
    Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric analysis of surface membrane proteins on activated platelets and platelet-derived microparticles from healthy and thrombasthenic individuals.
    Nomura S; Komiyama Y; Murakami T; Funatsu A; Kokawa T; Sugo T; Matsuda M; Yasunaga K
    Int J Hematol; 1993 Oct; 58(3):203-12. PubMed ID: 8148498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembly of the intrinsic factor X activating complex--interactions between factor IXa, factor VIIIa and phospholipid.
    van Dieijen G; van Rijn JL; Govers-Riemslag JW; Hemker HC; Rosing J
    Thromb Haemost; 1985 Jun; 53(3):396-400. PubMed ID: 3931288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coordinate binding studies of the substrate (factor X) with the cofactor (factor VIII) in the assembly of the factor X activating complex on the activated platelet surface.
    Ahmad SS; Walsh PN
    Biochemistry; 2002 Sep; 41(37):11269-76. PubMed ID: 12220193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the second growth-factor domain of human factor IXa in binding to platelets and in factor-X activation.
    Ahmad SS; Rawala R; Cheung WF; Stafford DW; Walsh PN
    Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):427-31. PubMed ID: 7654178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative interactions of factor IX and factor IXa with human platelets.
    Ahmad SS; Rawala-Sheikh R; Walsh PN
    J Biol Chem; 1989 Feb; 264(6):3244-51. PubMed ID: 2492533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of sodium ion binding on factor IXa activity.
    Gopalakrishna K; Rezaie AR
    Thromb Haemost; 2006 Jun; 95(6):936-41. PubMed ID: 16732371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of electrostatic interactions in the assembly of the factor X activating complex on both activated platelets and negatively-charged phospholipid vesicles.
    London F; Walsh PN
    Biochemistry; 1996 Sep; 35(37):12146-54. PubMed ID: 8810922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A binding site expressed on the surface of activated human platelets is shared by factor X and prothrombin.
    Scandura JM; Ahmad SS; Walsh PN
    Biochemistry; 1996 Jul; 35(27):8890-902. PubMed ID: 8688425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of phage display for the generation of human antibodies that neutralize factor IXa function.
    Suggett S; Kirchhofer D; Hass P; Lipari T; Moran P; Nagel M; Judice K; Schroeder K; Tom J; Lowman H; Adams C; Eaton D; Devaux B
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):27-42. PubMed ID: 10691097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial activation of the factor VIIIa-factor IXa enzyme complex by dihexanoic phosphatidylserine at submicellar concentrations.
    Gilbert GE; Arena AA
    Biochemistry; 1997 Sep; 36(35):10768-76. PubMed ID: 9271508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative platelet binding and kinetic studies with normal and variant factor IXa molecules.
    Ahmad SS; Rawala-Sheikh R; Monroe DM; Roberts HR; Walsh PN
    J Biol Chem; 1990 Dec; 265(34):20907-11. PubMed ID: 2249997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin.
    Baglia FA; Walsh PN
    Biochemistry; 1998 Feb; 37(8):2271-81. PubMed ID: 9485373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein S down-regulates factor Xase activity independent of activated protein C: specific binding of factor VIII(a) to protein S inhibits interactions with factor IXa.
    Takeyama M; Nogami K; Saenko EL; Soeda T; Nishiya K; Ogiwara K; Yoshioka A; Shima M
    Br J Haematol; 2008 Nov; 143(3):409-20. PubMed ID: 18759761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin inhibits the intrinsic tenase complex by interacting with an exosite on factor IXa.
    Sheehan JP; Kobbervig CE; Kirkpatrick HM
    Biochemistry; 2003 Sep; 42(38):11316-25. PubMed ID: 14503882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
    Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
    Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.